| Document |
Document Title |
|
JP2010268797A |
To provide methods for producing PHA polymers or copolymers that avoids increasing the level of 3-hydroxyacid in the feed.The method for PHA polymer production by coenzyme A-dependent aldehyde dehydrogenase pathways, includes expressing ...
|
|
JP2010536397A |
In one aspect, the present disclosure relates to a surgical device including an anchor body having an opening, the anchor body having a copolymer composition including polylactide-co-glycolide and calcium carbonate, wherein the calcium c...
|
|
JP4583566B2 |
|
|
JP2010239981A |
To provide a lubricative film composition for forming a lubricative film excellent in the adhesiveness, chemical resistance, abrasion resistance and lubricity.The lubricative film composition includes hydrophilic polymer including a stru...
|
|
JP2010240415A |
To perform improvement in the field of orthopedic fixation devices.An implant includes at least two degradation zones, each of which has a degradation rate, wherein the first degradation zone 34 degrades by surface erosion and the second...
|
|
JP2010220746A |
To provide a medical instrument and a medical material using an aliphatic polyester resin composition which show little change in weight average molecular weight during sterilization by ionizing radiation.The ionizing radiation sterilize...
|
|
JP4551353B2 |
An aqueous silicone coating composition containing a reactive siloxane polymer and a non-reactive dimethylpolysiloxane in an aqueous carrier having an effective amount of at least one dispersing agent to disperse the siloxanes throughout...
|
|
JP4554084B2 |
Bioabsorbable biocompatible polymers which provide a good match between their properties and those of certain tissue structures are provided. The bioabsorbable biocompatible polymers can be prepared with tensile strengths, elongation to ...
|
|
JP2010530896A |
The present invention provides a composition, and a method of use thereof, for treating connective tissue damage in man and in animals, which comprises a therapeutically effective amount of chondroitin sulfate, N-acetyl D-glucosamine, an...
|
|
JP4543271B2 |
A medical material which contains a lactide-containing polymer having weight-average molecular weight lower than 400000 as determined by GPC and has a lactide content of 4000 ppm or lower.
|
|
JP2010529213A |
The present invention relates to methods for making cross-linked, oxidatively stable, and highly crystalline polymeric materials. The invention also provides methods of treating irradiation-cross-linked antioxidant-containing polymers an...
|
|
JP2010184109A |
To provide a barbed suture which has a sufficient knot tensile strength, makes the gap formation of a wound minimum, and can promote the healing of the wound.The barbed suture 10 is for connecting tissue and a combination of a surgical n...
|
|
JP2010527746A |
A method for depositing a coating comprising a polymer and impermeable dispersed solid on a substrate, comprising the following steps: discharging at least one impermeable dispersed solid in dry powder form through a first orifice; disch...
|
|
JP4526487B2 |
An implantable prosthesis comprising an expanded polytetraethylene member having pores present in its wall structure wherein said pores contain a solid insoluble biocompatible, biodegradable material of natural origin. A process of prepa...
|
|
JP4524923B2 |
A polymer having a satisfactory balance between in vivo degradability and satisfactory mechanical properties, which is an A<1>BA<2> type polymer comprising a segment A<1> and a segment A<2> each having a modified amino acid and a segment...
|
|
JP4526832B2 |
|
|
JP2010527401A |
An antimicrobial material is provided for use in forming textiles, medical devices, packaging materials, and the like, or coatings thereon. In some embodiments, the antimicrobial material may be utilized for bulk modification of an artic...
|
|
JP2010527402A |
The present disclosure provides copolymers including a first monomer including at least one phospholipid possessing at least one vinyl group and a second monomer including a furanone possessing vinyl and/or acrylate groups. Compositions,...
|
|
JP4496316B2 |
Biodegradable terephthalate polymers are described comprising the recurring monomeric units shown in formula I:wherein R is a divalent organic moiety;R' is an aliphatic, aromatic or heterocyclic residue;x is >=1; andn is 0-5,000,wherein ...
|
|
JP4496360B2 |
|
|
JP2010522036A |
A suture coated with a composition comprising: a) a growth factor, b) a biodegradable, non-polymeric, non-water soluble, liquid carrier material (such as SAIB), c) a growth factor stabilizer, d) a solvent in which both the biodegradable,...
|
|
JP4493501B2 |
This invention relates to an unidirectional barbed suture for connecting human or animal tissue, said suture comprising an elongated body having a longitudinal axis, a cross-sectional distance or diameter (SD), a first end and a second e...
|
|
JP2010521246A |
The present disclosure provides surface-binding cell adhesion polypeptides including cell adhesion polypeptides attached to a surface-binding moiety having binding affinity for one or more materials present in a metallic and/or non-metal...
|
|
JP2010520761A |
Abstract Markers, antibodies and recombinant scFvs for Mesenchymal Stem Cell sub-populations and osteoclasts. The present invention relates to specific epitopes of surface membrane bound glycoproteins expressed by mesenchymal stem cells ...
|
|
JP4481488B2 |
A biodegradable, biocompatible polymer, comprising a combination of monomeric repeating units having structures I and IV wherein R9 is an alkyl, aryl or alkylaryl group with up to 18 carbon atoms having a pendant benzyl carboxylic acid e...
|
|
JP2010520029A |
Disclosed are implantable medical devices comprising nitric oxide (NO) donating polymers comprising polymer backbones having at least one cyclic amine disposed thereon. Methods are further disclosed for providing nitric oxide-donating po...
|
|
JP2010520181A |
Osteopontin for the prediction and treatment of cardiovascular diseases The present invention relates to the use of endothelial progenitor cells (EPCs) and osteopontin for the treatment of cardiovascular diseases or complications. The in...
|
|
JP4476123B2 |
An apparatus for inhibiting blood loss from a puncture site. The apparatus may include means for locating a puncture site in a blood vessel wall. This apparatus is comprised of a tube and an elongated member that is positioned around the...
|
|
JP2010518990A |
One aspect of the present invention relates to a method to control biological fluid flow at a site in a mammal by use of an in situ formed polymer plug. In certain embodiments, the present invention relates to a method to control bleedin...
|
|
JP4471342B2 |
Openings in a mammalian body made by any medical procedure or non-medical event are sealed with a bioabsorbable plug or sewn with a bioabsorbable suture. In one exemplary embodiment, the plug in dehydrated, unexpanded condition is pushed...
|
|
JP4471077B2 |
|
|
JP2010513678A |
The present disclosure provides compositions suitable for forming medical devices and coatings for medical devices, including sutures, which include a copolymer, at least one phosphorylcholine, and a fatty acid component. Sutures and oth...
|
|
JP2010095720A |
To provide a process for producing a polymer by using a hydroxamate, and to provide a polymer produced by the process.The polymer comprises a polymeric component and a hydroxamate of formula represented in the description. In the formula...
|
|
JP2010094514A |
To provide a medical device, a coating for the medical device and a process for manufacturing them.This coating for the medical device includes a copolymer containing a main amount of -caprolactone and a small amount of at least one kind...
|
|
JP2010088895A |
To provide a knotted end effector, and a method of making a knotted end effector.A suture includes: a body portion defining a longitudinal axis; and an end effector integrally formed from the body portion. The end effector includes first...
|
|
JP2010512230A |
Disclosed are compositions, methods and kits to control bleeding through the use of an internal occluder based on polymeric solutions, including use of reverse thermosensitive polymers in nephron-sparing surgeries, which produces a compl...
|
|
JP2010511427A |
Provided herein are implantable or insertable biomedical devices comprising a substrate and a collagen inhibitor on or in said substrate, and methods of treatment using the same. In some embodiments, the device is a urethral, ureteral, o...
|
|
JP4451929B2 |
Methods and support systems are provided for modifying the regeneration, differentiation, or function of cells. In one embodiment, electrically conducting biocompatible polymers may be used alone or in combination with a polymeric suppor...
|
|
JP2010077587A |
To provide a system and a method for effectively forming a loop in a suture before engaging the suture with a tissue.The system for making a looped suture having a tapered surface includes a base for selectively retaining a portion of th...
|
|
JP2010075922A |
To provide a method for coating a filament with a coating composition, and to provide a method in which the filament is wound around an outer periphery of a drum by this method.The method for coating the filament is provided, which inclu...
|
|
JP2010075692A |
To provide a biocompatible implant containing a polymer base material for in-situ implant fixation and a reactive component.This reactive surgical implant is a medical device which includes the base material which is combined with the re...
|
|
JP4445589B2 |
Fixed-dried human blood platelets and processes for preparing the same are disclosed. The platelets, upon reconstitution: adhere to thrombogenic surfaces; do not adhere to non-thrombogenic surfaces; undergo shape change (spreading) upon ...
|
|
JP4445697B2 |
An object of the present invention is to provide a means for improving the affinity of an in vivo embedded material such as an artificial blood vessel or an artificial dura mater with a tissue adhesive, so as to quickly prevent the leaka...
|
|
JP2010063459A |
To provide a method and a support system for modifying regeneration, differentiation or function of a cell.There are provided an electrically conducting biocompatible polymer which may be used alone or in combination with a polymeric sup...
|
|
JP2010063480A |
To provide a suture thread consisting of biocompatible thermoplastic resin, despite fine fibers, having a mechanical strength and flexibility being practical after a sterilization process and having a favorable handling property; and a m...
|
|
JP4434584B2 |
Methods of promoting angiogenesis by delivering angiogenic factors are disclosed. The factors can be delivered as a gradient to a localized area of tissue to direct vascular growth.
|
|
JP4425459B2 |
A fused loop of an elongated material, such as a surgical suture, and apparatus for making the loop. Portions of one or more segments to be joined together are fused in a welding process to form a welded joint. The shear area of the fuse...
|
|
JP2010042260A |
To provide a braided multi-filament suture thread representing a combination of desirable characteristics.A surgical device comprising a core having at least one filament, and a sheath which is disposed around the core and which includes...
|
|
JP2010505520A |
The present disclosure provides a medical device package including a container for receiving a medical device having an area configured for storing at least one agent and a port for permitting the passage of a contact material between th...
|
|
JP4421004B2 |
|
